The close relationship between ERα and proteasomes in malignant tumor cells was also confirmed by Thaler S. et al., who showed that bortezomib inhibited ERα expression and induced the death of ERα+ breast cancer cells [120]. Here, ESR1 is linked to breast carcinoma.